Discover the detailed record of transactions filed by Atkisson Erik, GC et Directeur de la Conformité. Officer active across 1 company, notably Eiger BioPharmaceuticals, Inc.. Cumulatively, 1 disclosures have been published. History available since 11 March 2022. The latest transaction was disclosed on 11 March 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Erik Atkisson is the GC & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. He is responsible for managing the company's legal affairs and regulatory compliance. His expertise in law and compliance is essential for protecting the interests of Eiger BioPharmaceuticals, Inc. and ensuring that the company complies with applicable laws.